Rapafusyn Pharmaceuticals to Present at the H.C. Wainwright 28th Annual Global Investment Conference
BALTIMORE, Sept. 2, 2026 /PRNewswire/ -- Rapafusyn Pharmaceuticals, a leader in the discovery and development of non-degrading molecular glue therapeutics, today announced that Dr. Sean Hu, President and Chief Executive Officer of Rapafusyn Pharmaceuticals, will present a company overview...
Covered in this story
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.